SINOMED
Eric Cao, MBA, M.Sc, serves as the Executive Vice President of Corporate Development at SINOMED since February 2014, where responsibilities include formulating a $15 billion corporate strategy through various investment and partnership strategies. Previously, Eric held the position of Global Vice President of Clinical and Regulatory Affairs, managing multiple functions across North America and Japan with a substantial budget. Additionally, Eric has extensive experience in R&D leadership roles at APT Medical, Cordis (Johnson and Johnson), and Novamed International LLC, among others. Eric's academic credentials include an Executive MBA from UCLA Anderson School of Management and a Master of Science in Mechanical Engineering from the University of California, Berkeley.
This person is not in any teams
This person is not in any offices
SINOMED
SINOMED is a global medical device company engaged in research, development, production, and commercial distribution of interventional devices. We are focused on developing breakthrough technologies to target unmet clinical needs in the interventional treatment of coronary, neurovascular and structural heart disease. Our mission is to become one of the global market leaders in providing valued medical devices in the fields in which we are active. Through our efforts, we aim to expose more patients to the benefits of our medical innovations, increasing patient longevity and quality of life.